| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1538 |
| Trial ID | NCT02465983 |
| Disease | Pancreatic Cancer |
| Altered gene | MESO|CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/MESO CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer |
| Year | 2015 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | UPCC 19214, 821275|UPCC 19214|UCSF CC144520 |
| Vector information | |||||
|
|||||
| Cohort1: MESO | |||||||||||||
|
|||||||||||||
| Cohort2: CD19 | |||||||||||||
|
|||||||||||||